Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Why Humana (HUM) Stock Is Trading Up Today

HUM Cover Image

What Happened?

Shares of health insurance company Humana (NYSE: HUM) jumped 2.3% in the morning session after the company announced a new initiative with Providence, a Washington-based health system, to streamline and secure data exchange in support of value-based care. The collaboration aimed to create a scalable system for seamless data sharing, enabling clinicians to deliver more effective care while reducing administrative tasks for members. Humana's President of Insurance, George Renaudin, stated that the effort would help members spend less time on paperwork and more time on their health. 

After the initial pop the shares cooled down to $282.32, up 2.7% from previous close.

Is now the time to buy Humana? Access our full analysis report here.

What Is The Market Telling Us

Humana’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 6 days ago when the stock dropped 3.8% on the news that the company lost a key lawsuit aimed at reversing cuts to Medicare bonus payments and received a new "sell" rating from Goldman Sachs. 

A Texas judge ruled in favor of the federal government, upholding a downgrade of quality ratings tied to Medicare Advantage payments. This decision threatened billions of dollars in potential revenue for the company. Adding to the pressure, a Goldman Sachs analyst initiated coverage on Humana with a sell rating and a $235 price target, which was substantially below the stock's previous closing price. The analyst also noted a longer path to recovery for the company's Medicaid and healthcare exchange businesses. These developments compounded existing concerns, as Humana also faced a class-action lawsuit alleging it had downplayed the impact of rising medical costs from pent-up demand for healthcare procedures.

Humana is up 11.7% since the beginning of the year, but at $282.32 per share, it is still trading 9.5% below its 52-week high of $312 from September 2025. Investors who bought $1,000 worth of Humana’s shares 5 years ago would now be looking at an investment worth $646.93.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  219.21
+2.73 (1.26%)
AAPL  264.16
+1.92 (0.73%)
AMD  239.62
-0.94 (-0.39%)
BAC  52.19
+0.15 (0.29%)
GOOG  254.44
-2.58 (-1.00%)
META  733.89
+1.72 (0.23%)
MSFT  517.29
+0.50 (0.10%)
NVDA  181.66
-0.98 (-0.54%)
ORCL  273.72
-3.46 (-1.25%)
TSLA  447.31
-0.12 (-0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.